FDA Brief

Warning letters Biologics

FDA warning letter to

Pinnacle Transplant Technologies, LLC

Issued Oct 1, 2024Posted Oct 22, 2024Center for Biologics Evaluation and Research (CBER)

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.